Executives also said demand for capital equipment continues to be healthy. However, investors may have expected stronger order growth.

Jake Leach will take over the role at the start of 2026, with Sayer remaining chairman of the board after the transition.

The company predicted a full-year impact of 200 million to 250 million euros, down from its previous forecast of up to 300 ...

This earnings season, top medical device companies have dramatically reduced their expectations for tariff impacts in 2025.